[Treatment of amebiasis with drugs acting on intestinal lumen and tissue].
D000081:Acetamides / Q000627:therapeutic use*; D000563:Amebicides / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004404:Dysentery, Amebic / Q000188:drug therapy*; D004987:Ethers / Q000627:therapeutic use*; D006801:Humans; D007408:Intestinal Absorption; D007413:Intestinal Mucosa / Q000187:drug effects*; D009593:Nitroimidazoles / Q000627:therapeutic use*; D010634:Phenobarbital / Q000008:administration & dosage; D014011:Tinidazole / Q000008:administration & dosage / Q000627:therapeutic use*
D000081:Acetamides; D000563:Amebicides; D004987:Ethers; D009593:Nitroimidazoles; D014011:Tinidazole; D010634:Phenobarbital
Tratamiento de la amibiásis con medicamentos de acción luminal y tisular.